Genetron
Genetron Health Nabs CE Mark for Blood Cancer Residual Disease Test Kit
The assay uses the company's "One-step Seq" method to detect cancer-associated DNA sequences in bone marrow from patients with certain hematologic cancers.
Genetron Health Adds New Assays to Pipeline While Anticipating MRD Launch, Liver Cancer Kit Trials
Premium
As it eyes new targets, the firm is poised to launch its personalized solid tumor MRD assay this year and is progressing toward approval for a liver cancer early detection IVD.
Genetron Health Q4 Revenues Up 10 Percent
The company's IVD sales revenue rose significantly, offsetting a quarter-over-quarter drop in revenue from in-house LDT serves.
Arima Genomics Closes $7M Series B Round
The San Diego-based company is planning to use the money to scale up its 3D genomics product and services while expanding operations worldwide.
Fulgent Genetics, Bio-Techne Lead Winners as GenomeWeb Index Gains 12 Percent in 2021
While Fulgent's stock price nearly doubled, at the other end of the spectrum, Berkeley Lights saw an 80 percent decline in its share price.
Jan 3, 2022
GW Index Rises 3 Percent in December
May 24, 2021
Genetron Health Q1 Revenues up 20 Percent
Mar 25, 2021